This intervention induced immune cell activation, significantly enhancing tumor and hepatic infiltration of NKT, NK, CD4+, and CD8+ T cells while elevating cytokine and chemokine levels in both serum and tumor microenvironments - establishing a novel immunotherapeutic approach for hepatocellular carcinoma. This evidence concerns the gene CD8A and neoplasm.